Masten Jeffrey L. 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Feb 21, 2012
Insider Transaction Report
Form 4
Masten Jeffrey L.
V.P. Quality
Transactions
- Award
Incentive Stock Options (right to buy)
2012-02-17+21,750→ 177,853 totalExercise: $0.95From: 2012-05-17Exp: 2022-02-17→ Common Stock (21,750 underlying) - Award
Non-Qualified Stock Options (right to buy)
2012-02-17+36,250→ 214,103 totalExercise: $0.95From: 2012-05-17Exp: 2022-02-17→ Common Stock (36,250 underlying)
Footnotes (1)
- [F1]This option vests quarterly over a two year period.